ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05032	Morphine addiction	13/169	110/7206	1.50492165403e-06
ko05033	Nicotine addiction	7/169	56/7206	0.000303599867257
ko04144	Endocytosis	19/169	342/7206	0.000631048265857
ko04727	GABAergic synapse	9/169	110/7206	0.001058974331
ko04360	Axon guidance	14/169	233/7206	0.0010994477924
ko04071	Sphingolipid signaling pathway	11/169	162/7206	0.00142735987142
ko04550	Signaling pathways regulating pluripotency of stem cells	11/169	165/7206	0.00165475687309
ko04721	Synaptic vesicle cycle	7/169	80/7206	0.00259822053513
ko00604	Glycosphingolipid biosynthesis - ganglio series	3/169	14/7206	0.0038130337756
ko04390	Hippo signaling pathway	11/169	188/7206	0.00456655460069
ko04080	Neuroactive ligand-receptor interaction	19/169	423/7206	0.00686789225543
ko04723	Retrograde endocannabinoid signaling	10/169	175/7206	0.00793046793167
ko04725	Cholinergic synapse	9/169	160/7206	0.0127218820129
ko04933	AGE-RAGE signaling pathway in diabetic complications	8/169	135/7206	0.0138098992879
ko05210	Colorectal cancer	6/169	86/7206	0.0152667827287
ko04070	Phosphatidylinositol signaling system	7/169	112/7206	0.0159140887366
ko04710	Circadian rhythm	4/169	43/7206	0.0176966414281
ko04391	Hippo signaling pathway - fly	6/169	90/7206	0.0187378239977
ko05205	Proteoglycans in cancer	1/169	271/7206	0.022052191309
ko04072	Phospholipase D signaling pathway	10/169	197/7206	0.0259636444924
ko04921	Oxytocin signaling pathway	10/169	209/7206	0.0313814181942
ko04350	TGF-beta signaling pathway	6/169	103/7206	0.0336481066728
ko04915	Estrogen signaling pathway	7/169	131/7206	0.0340100236417
ko04925	Aldosterone synthesis and secretion	6/169	105/7206	0.0364711469518
ko04930	Type II diabetes mellitus	4/169	54/7206	0.037248868063
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	5/169	79/7206	0.0374984738669
ko04024	cAMP signaling pathway	12/169	279/7206	0.0399950217668
ko04728	Dopaminergic synapse	9/169	185/7206	0.041338084851